Her 2 Negative Breast Cancer Clinical Trials

ReadTheTrial indexes 1 studies for Her 2 Negative Breast Cancer. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

1 clinical trials found for Her 2 Negative Breast Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 1
100%

Trial Status Breakdown

Trials for Her 2 Negative Breast Cancer

A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates（MBC-EA-II-01）

NCT07520760 · RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Her 2 Negative Breast Cancer?

There are 1 clinical trials listed for Her 2 Negative Breast Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Her 2 Negative Breast Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Her 2 Negative Breast Cancer trials in?

Current Her 2 Negative Breast Cancer trials are distributed across: Phase 2 (1).

Find More Trials